SCHEMBL930755

SCHEMBL930755

CC(C)c1c[c]ccc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 7/20 0.48
GABRB2 P47870 4/20 0.48
GABRB1 P18505 4/20 0.39
LMNA P02545 3/20 0.39
SLC6A2 P23975 2/20 0.39
HTR2B P41595 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
TSHR P16473 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
PTGS1 P23219 2/20 0.39
FAAH O00519 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
HTR2C P28335 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5366216 0.82 GABRA1 (0.48) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL930890 0.81 TSHR (0.53) GABRA1GABRB2TSHRHPGDHSP90AA1
SCHEMBL5074476 0.79 MEN1 (0.36) GABRA1GABRB2TSHR
SCHEMBL698305 0.78 GABRA1 (0.33) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL2195862 0.77 TYR (0.50) GABRA1GABRB2LMNATSHRPTGS1
SCHEMBL10887452 0.76 LMNA (0.32) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL3090389 0.73 LMNA (0.32) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL2267523 0.73 FAAH (0.30) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL1651125 0.73 GABRA1 (0.32) GABRA1GABRB2GABRB1LMNASLC6A2
SCHEMBL27844320 0.73 FAAH (0.30) GABRA1GABRB2GABRB1LMNASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107750264-A Rubber composition containing main chain benzoxazine and preparation method thereof 可隆工业株式会社 2018-03-02 CN claimed
CN-103408442-A Aromatic diamine monomer containing bis(trifluoromethyl), bisisopropyl and fluorenyl structures simultaneously, and preparation method and application thereof UNIV CHANGZHOU 2013-11-27 CN claimed
US-7271183-B2 2-Piperidone derivatives as prostaglandin agonists ROCHE PALO ALTO LLC (US) 2007-09-18 US claimed
CN-113785023-B Water-based ink composition for reversible thermochromic writing instrument, refill for refill and water-based ballpoint pen incorporating same 株式会社百乐 2023-05-12 CN disclosed
CN-113785023-A Water-based ink composition for reversible thermal discoloration writing instrument, refill containing the same, and water-based ballpoint pen 株式会社百乐 2021-12-10 CN disclosed
CN-108350159-B Method for producing resin composition 三菱瓦斯化学株式会社 2021-09-21 CN disclosed
CN-109593196-B Resin produced by polycondensation and resin composition 三菱瓦斯化学株式会社 2021-08-13 CN disclosed
CN-108350262-B Resin composition, and optical lens, sheet and film each comprising same 三菱瓦斯化学株式会社 2021-07-30 CN disclosed
CN-108350161-B Polycarbonate resin 三菱瓦斯化学株式会社 2020-06-16 CN disclosed
CN-109562944-A hard mask composition 亚历克斯·菲利普·格雷厄姆·罗宾逊 2019-04-02 CN disclosed
CN-107207889-A For making the polyester dispersants that ceramic tile is coloured using ink jet type ink and ink-jet printer 路博润先进材料公司 2017-09-26 CN disclosed
US-20100016633-A1 such as bis(3-formyl-4-(4-methoxycarbonylphenyl)methoxyphenyl)methane, by reacting bis(hydroxymethyl-hydroxyphenyl)alkane with hexamethylene tetramine in presence of acid and hydrolyzing, then reacting with halogenated alkoxycarbonyl hydrocarbon in presence of base HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-01-21 US disclosed
CN-101119747-A Tissue factor production inhibitor SANKYO CO (JP) 2008-02-06 CN disclosed
CN-1930006-A Developer mixture for thermal recording materials and thermal recording materials API CORP (JP) 2007-03-14 CN disclosed
US-4806675-A CATALYTIC ESTERIFICATION WITH HYDROXYALKANOIC AND THIOALKANOIC ACIDS; HEAT AND OXIDATION RESISTANCE MALLINCKRODT, INC. (US) 1989-02-21 US disclosed
US-4794138-A STABILIZERS OF ORGANIC MATERIAL NORMALLY SUSCEPTIBLE TO OXIDATIVE AND/OR THERMAL DETERIORATION MALLINCKRODT, INC. (US) 1988-12-27 US disclosed
US-4772741-A STABILIZERS FOR POLYMERS MILLINCKRODT, INC. (US) 1988-09-20 US disclosed
US-4734519-A STABILIZERS MALLINCKRODT, INC. (US) 1988-03-29 US disclosed
EP-0250087-A1 Pentaerythritol co-esters MALLINCKRODT, INC. (US) 1987-12-23 EP disclosed
US-4098760-A NON-MIGRATORY, NON-LEACHING UNIROYAL, INC. (US) 1978-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016633-A1 such as bis(3-formyl-4-(4-methoxycarbonylphenyl)methoxyphenyl)methane, by reacting bis(hydroxymethyl-hydroxyphenyl)alkane with hexamethylene tetramine in presence of acid and hydrolyzing, then reacting with halogenated alkoxycarbonyl hydrocarbon in presence of base PAH, PGM2, HNMT GABRA1 3928/4885GABRB2 4543/4885GABRB1 4489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.